Results

Total Results: 334 records

Showing results for "phase".

41. Archived: Final Evidence Summary: Healthy Diet and Physical Activity: Counseling for CVD Prevention in Adults | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary27/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults-2012
    December 15, 2010 - Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:1213-20. … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Phase I design. Ann Epidemiol. 1991;1:455-71. … The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157: 657-67. … Trials of Hypertension Prevention (phase II).

42. Behavioral Counseling to Promote Physical Activity and a Healthful Diet to Prevent Cardiovascular Disease in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DHThYFr24GVDzHq7rsxoPm
    December 01, 2010 - Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:1213-20. … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Phase I design. Ann Epidemiol. 1991;1:455-71. [PMID: 1669525] 96. … The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157: 657-67. … Trials of Hypertension Prevention (phase II).

43. Behavioral Counseling to Promote Physical Activity and a Healthful Diet to Prevent Cardiovascular Disease in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/bF5BNLvASN5r9EnP3VTJPN
    December 01, 2010 - Results of the Trials of Hypertension Prevention, Phase I. JAMA. 1992;267:1213-20. … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Phase I design. Ann Epidemiol. 1991;1:455-71. [PMID: 1669525] 96. … The Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157: 657-67. … Trials of Hypertension Prevention (phase II).

44. Update on Methods: How To Read the New Recommendation Statement | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/update-methods-how-read-new-recommendation-statement
    April 01, 2019 - The recommendation phase for both GRADE 4-6  and the USPSTF rely on a judgment of net benefits (benefits … the GRADE framework is not yet available, because several considerations in the GRADE recommendation phase

45. Draft Research Plan: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/weight-loss-prevent-obesity-related-morbidity-mortality
    May 18, 2023 - assessment KQs 1, 2: ≥12 months after baseline or beginning of weight loss or weight maintenance phase

46. Draft Research Plan: Healthy Diet, Physical Activity, and/or Weight Loss to Prevent Cardiovascular Disease in Adults: Behavioral Counseling Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/behavioral-counseling-interventions-promote-healthy-diet-physical-activity-weight-loss-prevent-cardiovascular-disease-adults
    May 18, 2023 - assessment KQs 1, 2: ≥12 months after baseline or beginning of weight loss or weight maintenance phase

47. Health Equity Framework for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2023-12/health-equity-framework-report.pdf
    January 01, 2023 - equity framework was used to organize a “checklist” of key items that could be considered at each phase … However, this may not be feasible to do during the Work Plan phase. … disparities in access to and receipt of preventive services should be addressed at the Work Plan phase … interventions (NRSIs) (e.g., comparative cohort studies) for evidence of benefit at the Work Plan phase … A decision to expand the evidence of benefit to include NRSI evidence at the Work Plan phase should

48. Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    June 11, 2019 - in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase … Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized … Safety and tolerability of maraviroc-containing regimens to prevent HIV infection in women: a phase 2 … Phase 2 study of the safety and tolerability of maraviroc-containing regimens to prevent HIV infection … Phase II safety and acceptability of an investigational injectable product, TMC278LA, for pre-exposure

49. Archived: Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
    June 11, 2019 - in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase … Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized … Safety and tolerability of maraviroc-containing regimens to prevent HIV infection in women: a phase 2 … Phase 2 study of the safety and tolerability of maraviroc-containing regimens to prevent HIV infection … Phase II safety and acceptability of an investigational injectable product, TMC278LA, for pre-exposure

50. Recommendation: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication
    November 01, 2022 - although the risk of breast cancer was not significantly lower during the study’s 7.2-year intervention phase … At 20.7 years of follow-up, persons who received estrogen alone during the intervention phase had a lower … risk of total fractures in persons taking estrogen alone compared with placebo during the intervention phase

51. Evidence Summary: Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Risk Factors: Behavioral Counseling | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-without-known-risk-factors-behavioral-counseling
    July 11, 2017 - 81 In contrast, long-term observational follow-up from the Trial of Hypertension Prevention (TOHP) phase … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Trials of Hypertension Prevention: phase I design. Ann Epidemiol. 1991;1(5):455-471. … blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase … Group counseling HD 78 High Research clinic   TOHP Collaborative Research Group (Phase

52. Archived: Evidence Summary: Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Risk Factors: Behavioral Counseling | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/healthful-diet-and-physical-activity-for-cardiovascular-disease-prevention-in-adults-without-known-risk-factors-behavioral-counseling-july-2017
    July 11, 2017 - 81 In contrast, long-term observational follow-up from the Trial of Hypertension Prevention (TOHP) phase … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Trials of Hypertension Prevention: phase I design. Ann Epidemiol. 1991;1(5):455-471. … blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase … Group counseling HD 78 High Research clinic   TOHP Collaborative Research Group (Phase

53. Draft Research Plan: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/weight-management-children-adolescents-interventions
    February 10, 2022 - KQs (except serious harms of pharmacotherapy): ≥12 months after baseline or beginning of weight loss phase

54. Draft Research Plan: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/high-body-mass-index-children-adolescents-interventions
    February 10, 2022 - KQs (except serious harms of pharmacotherapy): ≥12 months after baseline or beginning of weight loss phase

55. Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/6fFns4N2J-t5EGC5BUdRuu
    October 23, 2023 - long-acting injectable cabotegravir (600 mg intramuscularly every 8 weeks, following a 5-week oral lead-in phase … prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase … HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase … Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical … prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase

56. Recommendation: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    August 22, 2023 - long-acting injectable cabotegravir (600 mg intramuscularly every 8 weeks, following a 5-week oral lead-in phase … Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical … prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase … prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase … HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase

57. Behavioral Counseling to Promote a Healthy Diet and Physical Activity for CVD Prevention in Adults With Cardiovascular Risk Factors: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-97QgoUF_rpQSy-9yM9KCx
    November 24, 2020 - I Collaborative Research Group; TOHP II CRG, Trials of Hypertension Prevention–Phase II Collaborative … from the Trials of Hypertension Prevention phase II. … Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. … Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. … Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention.

58. Evidence Summary: Primary Open-Angle Glaucoma: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/primary-open-angle-glaucoma-screening
    May 24, 2022 - and latanoprost in ocular hypertension and open-angle glaucoma: pooled efficacy/safety analysis of phase … One year of netarsudil and latanoprost fixed-dose combination for elevated intraocular pressure: phase … netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized phase … Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with … Latanoprostene bunod 0.024%in subjects with open-angle glaucoma or ocular hypertension: pooled phase

59. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
    June 11, 2019 - in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase … Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized … Safety and tolerability of maraviroc-containing regimens to prevent HIV infection in women: a phase 2 … Phase 2 study of the safety and tolerability of maraviroc-containing regimens to prevent HIV infection … Phase II safety and acceptability of an investigational injectable product, TMC278LA, for pre-exposure

60. Zyao53-Sqrb6Ozzkzdmjjt (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZYao53-sqRb6oZzKzDmjjt
    December 01, 2003 - Placebo: 53.7 yrs Orlistat: 35.2 kg/m2 Placebo: 35.6 kg/m2 Karhunen 120 mg tid D N: 96 2 yrs: Loss phase … : advice throughout (Tx Yr 1/Tx Yr 2) the 1 yr loss phase Orlistat/Orlistat Orlistat/Placebo Placebo … ) reduction program) Walking program Not noted Nutritionist (4.2 MJ/wk target (weight loss phase), … expenditure) following exercise instructor 12-wk weight reduction (maintenance phase) program Walking … program Not noted Nutritionist (8.4 MJ/wk target (weight loss phase), expenditure) following exercise